Corbus Pharmaceuticals Holdings (CRBP) Current Leases (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Current Leases of $1.6 million for Q4 2025, up 1.68% year-over-year from $1.6 million in Q4 2024, and down 6.26% quarter-over-quarter from $1.7 million in Q3 2025.
Corbus Pharmaceuticals Holdings (CRBP) Current Leases (2018 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Current Leases history runs 8 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Current Leases rose 1.68% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (up 1.68% YoY), while the FY2025 annual figure was $1.6 million, up 1.68% from the prior year.
- Current Leases for Q4 2025 stood at $1.6 million, down from $1.7 million in the prior quarter.
- The five-year high for Current Leases was $1.7 million in Q3 2025, with the low at $1.0 million in Q1 2021.
- The 5-year median for Current Leases is $1.4 million (2023), against an average of $1.4 million.
- The sharpest annual moves came in 2021 and 2025: Current Leases surged 39.49% in 2021, then climbed 1.68% in 2025.
- Corbus Pharmaceuticals Holdings' Current Leases stood at $1.1 million in 2021, then grew by 12.66% to $1.3 million in 2022, then climbed by 12.19% to $1.4 million in 2023, then climbed by 11.76% to $1.6 million in 2024, then increased by 1.68% to $1.6 million in 2025.
- Business Quant data shows CRBP's Current Leases at $1.6 million in Q4 2025, $1.7 million in Q3 2025, and $1.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 122.80 Mn | -40.47 Mn | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.04 Mn |